.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Merck
Queensland Health
Citi
Deloitte
Cipla
Daiichi Sankyo
Julphar
AstraZeneca

Generated: July 24, 2017

DrugPatentWatch Database Preview

Octreotide acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for octreotide acetate and what is the scope of octreotide acetate freedom to operate?

Octreotide acetate
is the generic ingredient in five branded drugs marketed by Novartis, West-ward Pharms Int, Sun Pharm Inds, Sagent Pharms, Fresenius Kabi Usa, Teva Pharms Usa, Wockhardt Usa, and Mylan Institutional, and is included in eighteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Octreotide acetate has thirty-seven patent family members in twenty-five countries.

There are eighteen drug master file entries for octreotide acetate. Nine suppliers are listed for this compound.

Summary for Generic Name: octreotide acetate

Tradenames:5
Patents:3
Applicants:8
NDAs:18
Drug Master File Entries: see list18
Suppliers / Packagers: see list9
Bulk Api Vendors: see list70
Clinical Trials: see list1,078
Patent Applications: see list6,927
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:octreotide acetate at DailyMed

Pharmacology for Ingredient: octreotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms
OCTREOTIDE ACETATE
octreotide acetate
INJECTABLE;INJECTION091041-002Nov 12, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
OCTREOTIDE ACETATE
octreotide acetate
INJECTABLE;INJECTION077373-002Aug 14, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008-002Nov 25, 1998RXYesNo► Subscribe► SubscribeY► Subscribe
Novartis
SANDOSTATIN
octreotide acetate
INJECTABLE;INJECTION019667-001Oct 21, 1988APRXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
octreotide acetate
INJECTABLE;INJECTION076313-002Mar 28, 2005APRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: octreotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
SANDOSTATIN
octreotide acetate
INJECTABLE;INJECTION019667-002Oct 21, 1988► Subscribe► Subscribe
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008-001Nov 25, 1998► Subscribe► Subscribe
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008-002Nov 25, 1998► Subscribe► Subscribe
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008-002Nov 25, 1998► Subscribe► Subscribe
Novartis
SANDOSTATIN
octreotide acetate
INJECTABLE;INJECTION019667-001Oct 21, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: octreotide acetate

Country Document Number Estimated Expiration
Australia3234884► Subscribe
Sweden8404225► Subscribe
Greece80184► Subscribe
Luxembourg85514► Subscribe
Spain8706750► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Moodys
Deloitte
Federal Trade Commission
Queensland Health
US Army
Johnson and Johnson
Baxter
Mallinckrodt
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot